Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

In 1981 and 1982 Haemophilia A patients were primarily treated at the Royal Manchester Childrens' Hospital with commercial concentrate and no NHS concentrate was used at all.

  • Read more about In 1981 and 1982 Haemophilia A patients were primarily treated at the Royal Manchester Childrens' Hospital with commercial concentrate and no NHS concentrate was used at all.

In 1980 significantly more units of concentrates (predominantly commercial) were used than cryoprecipitate at the Royal Manchester Childrens' Hospital.

  • Read more about In 1980 significantly more units of concentrates (predominantly commercial) were used than cryoprecipitate at the Royal Manchester Childrens' Hospital.

By 1979 for the first time more units of concentrates (predominantly commercial) were used than cryoprecipitate at the Royal Manchester Childrens' Hospital .

  • Read more about By 1979 for the first time more units of concentrates (predominantly commercial) were used than cryoprecipitate at the Royal Manchester Childrens' Hospital .

In 1976 the annual returns from the Royal Manchester Childrens' Hospital showed the use of 270,970 units of cryoprecipitate, 32,973 units of commercial concentrates and 3,535 units of NHS Factor 8.

  • Read more about In 1976 the annual returns from the Royal Manchester Childrens' Hospital showed the use of 270,970 units of cryoprecipitate, 32,973 units of commercial concentrates and 3,535 units of NHS Factor 8.

Dr Evans was concerned about the transmissibility of hepatitis to write to Professor Blackburn (then chair of UKHCDO) wanting to know what different laboratories were doing.

  • Read more about Dr Evans was concerned about the transmissibility of hepatitis to write to Professor Blackburn (then chair of UKHCDO) wanting to know what different laboratories were doing.

Letters were sent out to parents with their children's AIDS test results. There is also some evidence of two group meetings for parents being held at the RMCH.

  • Read more about Letters were sent out to parents with their children's AIDS test results. There is also some evidence of two group meetings for parents being held at the RMCH.

There was a smaller centre at Booth Hall Children's Hospital, where Dr Evans was the director and small numbers of patients were treated each year

  • Read more about There was a smaller centre at Booth Hall Children's Hospital, where Dr Evans was the director and small numbers of patients were treated each year

The Royal Manchester Children's Hospital treated children up to the age of 16 or 17 years.

  • Read more about The Royal Manchester Children's Hospital treated children up to the age of 16 or 17 years.

Dr Hill reported to Armour that a third child had seroconverted.

  • Read more about Dr Hill reported to Armour that a third child had seroconverted.

Of two boys who had seroconverted, Dr Hill stated that number 2 was treated with NHS product only, and number 1 was just unlucky as they had had only a moderate amount of treatment.

  • Read more about Of two boys who had seroconverted, Dr Hill stated that number 2 was treated with NHS product only, and number 1 was just unlucky as they had had only a moderate amount of treatment.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Current page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.